HealthEquityFRA:2HE +1.91%93 Days Payable is 12.21 as of Apr. 2026, which is 4% above its 10-year median of 11.75. GuruFocus rates FRA:2HE with a GF Score™ of 93/100 and a GF Value™ of €86.54. The stock has 3 warning signs investors should review. Among 607 Healthcare Providers & Services companies, HealthEquity ranks worse than 90.12% on this metric.
The historical rank and industry rank for HealthEquity's Days Payable or its related term are showing as below:
FRA:2HE'
s Days Payable Range Over the Past 10 Years
Min: 3.21 Med: 11.75 Max: 20.45
Current: 12.85
During the past 13 years, HealthEquity's highest Days Payable was 20.45. The lowest was 3.21. And the median was 11.75.
FRA:2HE's Days Payable is ranked worse than 90.12% of 607
companies
in the Healthcare Providers & Services industry
Industry Median: 58
vs FRA:2HE: 12.85
HealthEquity's Days Payable
declined
from Apr. 2025 (12.46) to Apr. 2026 (12.21).
It may suggest that HealthEquityaccelerated paying its suppliers.
HealthEquity Days Payable Related Terms
HealthEquity Days Payable Historical Data
* Premium members only.
The historical data trend for HealthEquity's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:2HE vs HNGE, TEM, TXG: Days Payable Comparison
For the Health Information Services subindustry, HealthEquity's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HealthEquity Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, HealthEquity's Days Payable distribution charts can be found below:
* The bar in red indicates where HealthEquity's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
HealthEquity's Days Payable for the fiscal year that ended in Jan. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HealthEquity (FRA:2HE) has a Days Payable of 12.21 as of Apr. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on HealthEquity and its competitors. This is near median its historical median of 11.75. Over the past decade, HealthEquity's Days Payable has ranged from 3.21 to 20.45. According to the industry distribution chart, HealthEquity ranks #547 out of 607 companies in the Healthcare Providers & Services industry, placing it in the top 90.1%.
Is HealthEquity's Days Payable too high?
HealthEquity's current Days Payable of 12.21 is near median its 10-year median of 11.75. Over the past 10 years, this metric has ranged from a low of 3.21 to a high of 20.45. The Healthcare Providers & Services industry median Days Payable is 58.00. HealthEquity's value of 12.21 is 78.9% below this industry median. Based on the distribution chart, HealthEquity ranks #547 out of 607 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, HealthEquity has a GF Score™ of 93/100, reflecting its overall financial health beyond just this single metric.
How does HealthEquity's Days Payable compare to HNGE and TEM?
According to the Healthcare Providers & Services industry distribution chart, HealthEquity ranks #547 out of 607 companies for Days Payable. This places HealthEquity in the lower half of its industry. The industry median Days Payable is 58.00. HealthEquity's value of 12.21 is 78.9% below this benchmark. Historically, HealthEquity's own Days Payable has ranged from 3.21 to 20.45 over the past decade. While the company's 10-year median is 11.75 vs. the industry median of 58.00, HealthEquity has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.00, based on 607 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HealthEquity's current Days Payable of 12.21 is 78.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on HealthEquity and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HealthEquity's current Days Payable is 12.21, which is near median its own 10-year median of 11.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HealthEquity stock overvalued right now?
HealthEquity (FRA:2HE) has a current Days Payable of 12.21. The stock's GF Value™ is €86.54, compared to a current price of €80.00 — trading 7.6% below its estimated fair value. The current Days Payable is 12.21, which is near median its 10-year median of 11.75 and 78.9% below the Healthcare Providers & Services industry median of 58.00. HealthEquity's overall GF Score™ is 93/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For HealthEquity (FRA:2HE), the current Days Payable is 12.21 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is HealthEquity (FRA:2HE) Overvalued in 2026?
Based on GuruFocus' analysis, HealthEquity stock appears to be undervalued.
The current stock price of €80.00 is trading 7.6% below its estimated GF Value™ of €86.54.
Key valuation signals for FRA:2HE:
Days Payable: 12.21 (near median its 10-year median of 11.75)
GF Value™: €86.54 vs. price of €80.00 (7.6% below fair value)
Industry Position: 78.9% below the Healthcare Providers & Services median (#547 of 607)
No single metric tells the full story. See the FRA:2HE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
93GF Score
Get the complete analysis for FRA:2HE
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:2HE has been successfully added to your 
